News Articles 91 - 100 of 160

04
Jul
NICE - Invitation to apply for the role of appeal panel chair or lay member of Technology Appraisal or Highly Specialised Technologies Appeal Panels
News Type: BASL News

The National Institute for Health and Care Excellence (NICE) is looking to appoint a number of people with the necessary experience and skills to fulfill the following roles:

• Appeal panel chair
• Lay member

The appeal panel is responsible for hearing appeals against our draft final recommendations in the technology appraisal (new drugs and other technologies used in the NHS) and highly specialised technologies (the evaluation of technologies for treating patients with very rare diseases and very complex healthcare needs) programmes. When an appeal is submitted an appeal panel comprising five members is drawn from those appointed to hear NICE appeals.

Appeal panel chairs must either:
• currently provide healthcare in the NHS or public health service, or
• be a patient or carer, or a member of an organisation that represents patients or carers.

The lay representative must be a patient or carer, or a member of an organisation that represents patients or carers.
Appointees will need to be able to understand the process and methods NICE uses to appraise new health technologies and to critically assess the arguments put forward by companies, professional groups and patient organisations appealing against our guidance. In addition, chairs must demonstrate the personal qualities necessary to organise, lead and control a setting in which sometimes complex arguments are presented and challenged. Appeal panels are established infrequently and appointees may only need to sit on a panel two to three times a year.

NICE would welcome applicants from all interested parties. For further information on the role and how apply please refer to the NICE website: https://www.nice.org.uk/Get-Involved/join-a-committee . Alternatively you can contact Maria Pitan, Project Manager – Corporate Office by email maria.pitan@nice.org.uk.

The deadline for applications is 5pm on Monday 17 July 2017.

04
Jul
Improving Quality in Liver Services (IQILS)
News Type: BASL News

The Royal College of Physicians (RCP) has officially launched its new exemplar liver accreditation programme, Improving Quality in Liver Services (IQILS), led by Dr James Ferguson, clinical lead for the programme.

Born out of the successful LiverQuest pilot project, IQILS is supported by the British Association for the Study of the Liver (BASL) and the British Society of Gastroenterology (BSG) and has been shaped in partnership with the wider liver community, professional bodies, societies and patient groups.
Having taken learning and recommendations from the original LiverQuest pilot, the new accreditation scheme, will support liver services to deliver high-quality care for patients.

IQILS is open to all liver services across the UK, enabling them invaluable access to a new online tool, expertise and up to date guidance on improving standards and enhancing patient experience.

Thanks to the kind support of BASL, some services may also be eligible for an early bird discount.

For more details regarding the scheme, how to sign up, and discount eligibility, information can be found at www.iqils.org .

Alternatively, contact Madeline Corrigan, IQILS Programme Manager at the RCP at madeline.corrigan@rcplondon.ac.uk .

29
Jun
Publication of NICE Liver Disease Quality Standard
News Type: BASL News

We are pleased to announce that the liver disease quality standard (QS152) has been published on the NICE website today.

You can view the quality standard by clicking > here. 

BASL has formally supported the liver disease quality standard.

29
Jun
Alcohol Related Liver Disease PSP Final Report
News Type: BASL News

The Alcohol-Related Liver Disease (ARLD) PSP has been set up to identify unanswered questions about alcohol-related liver disease treatments from the point of view of patients, carers and healthcare professionals.

The identified questions will be prioritised, resulting in a list of the Top 10 priorities for research.

The objectives of the ARLD PSP are to:

• work with patients and clinicians to identify uncertainties about the effects of alcohol-related liver disease prevention and treatments
• to agree by consensus a prioritised list of those uncertainties for research
• to publicise the results of the PSP and process to the research community
• to take the results to the research commissioning bodies to be considered for funding.

Formed by the James Lind Alliance and funded by the National Institute for Health Research (NIHR) and the British Society of Gastroenterology (BSG), the PSP is being guided by a steering group of patient, carer and clinical group representatives.

Download the report Alcohol Related Liver Disease PSP Final Report here:  Download Alcohol-related Liver Disease PSP final report.pdf

Or visit the website to view the report by clicking > here

29
Jun
AHA comment: Minimum pricing in Wales
News Type: BASL News

Responding to the announcement (below) that the Welsh government is set to legislate for a minimum price for alcohol, Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:

Download Welsh government announcement.pdf

“We welcome the Welsh government’s announcement today that it will introduce legislation to set a minimum price for alcohol.

“The cheaper alcohol is, the more alcohol-related harm is done, and at present there is a proliferation of cheap alcohol across the UK. Raising the price of the cheapest alcohol by setting a price below which it cannot be sold will save lives, reduce hospital admissions and cut crime.

“With Scotland also set to introduce minimum unit pricing, it is vital that the UK government now legislates for minimum unit pricing for England too, something it committed to doing five years ago but failed to follow through. With lives being lost as a direct result of freely available cheap alcohol, a decision to delay further will be in effect a death sentence for some of the most vulnerable in society.”

About the Alcohol Health Alliance UK

The Alcohol Health Alliance UK (AHA) is a group of 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies.The AHA works together to:
• Highlight the rising levels of alcohol-related health harm
• Propose evidence-based solutions to reduce this harm
• Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at matt.chorley@rcplondon.ac.uk or on 0203 075 1726.

27
Jun
Vacancy - Senior Clinical Fellow in Hepatology - QEH Birmingham
News Type: BASL News

To view the details of the Senior Clinical Fellow in Hepatology post click > here.

22
Jun
Dame Shelia Sherlock Research Prize 2017 - apply now - deadline 4th August 2017
News Type: BASL News

Deadline: Friday 4th August 2017

Each year BASL presents the Dame Sheila Sherlock research prize, one of the highlights of the annual meeting. This prize is awarded annually to recognise the enormous contribution of Dame Sheila Sherlock to the development of Hepatology as a discipline in its own right.

When Dr Sherlock started her medical career, little was known about liver disease. Her work helped to establish hepatology as a medical specialty. She pioneered the use of needle liver biopsy, which had been used purely as a research tool, based on the technique of Sir John McMichael; this improved understanding of the pathology of liver disease and is used in the diagnosis of liver diseases today. The liver unit that she set up at the Royal Free Hospital became the centre for both research into liver disease and the education of trainees in the specialty.

Dame Sheila was involved in the foundation of the British Liver Club in 1961, which subsequently evolved into The British Association for the Study of the Liver (BASL). She was one of our past presidents and the first recipient of The BASL Distinguished Service Award.

In keeping with Dame Sheila’s enthusiasm for fostering young researchers, this eponymous research prize is awarded to young investigators without substantive posts in either medicine or science for their research contributions in the field of Hepatology.

The winner of the award will deliver a lecture presenting their research during the Annual Meeting, 20-22 September 2017. This year the prize is free registration to the meeting, a place at the Annual Dinner at Warwick Castle and £1,000.

To apply, please send one A4 sheet outlining the research and another A4 sheet detailing the related publications.

Please send submissions to steve@basl.org.uk before the deadline of midday on Friday 4th August 2017. 

22
Jun
Andy Burroughs Young Investigator Award 2017 - apply now - deadline 4th August 2017
News Type: BASL News

Deadline: Friday 4th August 2017

The Andy Burroughs Young Investigator Award was set up in honour of the late Professor Andrew Burroughs, who sadly passed away in March 2014. Professor Burroughs was an eminent and world renowned Professor of Hepatology and Consultant Physician/Hepatologist and among his many achievements was his significant contribution to liver transplantation.

This year the award will take place during the BLTG Transplant Meeting at Warwick Conference Centre, 19-20 September 2017.

This prize is awarded to young investigators, scientific or clinical, who are in training or within 2 years of taking up consultant positions (or equivalent) and the winner will deliver the prize lecture at the Meeting which will be being held at 11.30-12.10 on Tuesday 19th September, and will also receive free registration to the meeting and £1,000.

To apply, please send one A4 sheet outlining the research and another A4 sheet listing up to 5 related publications.

Please send submissions to steve@basl.org.uk before the deadline of midday on Friday 4th August 2017.

22
Jun
BASL Annual Meeting - Warwick Conference Centre - 20th - 22nd September 2017 - Registration now Open
News Type: BASL News

Please join us at Warwick University for the BASL 2017 Annual Conference where all of us interested in liver disease will share time whether we are clinicians, nurses, basic scientists, pharmacists, working in industry or students.

BASL follows seamlessly from the third meeting of the British Liver Transplant Group (BLTG), making it easy for the many delegates who want to attend both conferences. BLTG as ever includes the ‘Williams-Calne Lecture’, given this year by Professor Peter Friend (Oxford). An additional highlight is the state of the art lecture by Professor Geoff McCaughan (Sydney).

The BASL conference opens after lunch on Wednesday and will explore clinical and liver related aspects of senescence with a distinguished international faculty. A highlight of the meeting will be the state of the art lecture by Professor Judith Campisi (Buck Institute, California).

The second day has two streams: first, the interaction between the Liver and the Gut and second, the named lectures. These include the Ralph Wright Lecture (Professor John O’Grady) the British Liver Trust Lecture (Dr. Mary Ramsay), the inaugural Alex Mowat Lecture (Dr. Sue Beath) and the annual Dame Sheila Sherlock Prize Lecture.

The main poster session is on Wednesday evening with supper provided and the conference dinner (supported by BASL) is at Warwick Castle, a stunning venue, on Thursday evening.

The Nurses Day runs in parallel to the BASL meeting on Thursday 21st September and this year has especial importance as it will be celebrating the launch of the newly formed British Liver Nurses Association following a merger of the BLNF & the BASLNF. This day promises to deliver exciting and inspiring sessions for all nurses working within Hepatology, with the programme including a wide range of topics relating to liver disease and its associated issues and challenges.

There are considerable 'Early Bird' discounts available for BASL and BASLNF members and the deadline for early bird registration is Monday 31st July 2017.

View the Programme and Register now on the BASL Annual Meeting website for both meetings by clicking > here.

22
Jun
Enough alcohol sold in England for every drinker to consume 50% more than guideline levels
News Type: BASL News

New figures published today reveal that enough alcohol is being sold in England and Wales for every drinker to consume 21 units of alcohol a week – far more than the low-risk level of 14 units per week for both men and women recommended by the UK's chief medical officers.

The figures reveal that the situation is even worse in Scotland, with enough alcohol being sold for every drinker to consume 24 units a week.

The data was released by NHS Health Scotland, who also looked at consumption in England and Wales in order to compare patterns across the UK.

Roughly speaking, a regular-strength pint of beer and a 175ml glass of wine both contain 2 units of alcohol.

To tackle high levels of alcohol-related deaths and illness, Scotland is set to introduce a minimum unit price for alcohol, which would raise the price of the cheapest alcohol products which do the most harm. The Scottish government passed minimum unit pricing over 5 years ago, though implementation of the measure has so far been delayed due to legal challenges from the alcohol industry.

Minimum unit pricing formed part of the Westminster government's alcohol strategy in 2012, though has yet to be implemented in England and Wales.

Responding to the publication of the figures, Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:

"These figures are shocking and show why minimum unit pricing is needed in Scotland, as well as in the rest of the UK.
As a result of the legal challenges from the alcohol industry, lives will undoubtedly have been lost in Scotland. We hope and expect minimum unit pricing to be ruled legal in the final court hearing in this case in July, so that implementation in Scotland can follow.
If minimum unit pricing is ruled legal in Scotland, a decision by Westminster to delay would be a death sentence for some, including many from the lowest income groups. The evidence is already clear - minimum unit pricing saves lives, prevents illness and lowers hospital admissions."

About the Alcohol Health Alliance UK
The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:

· Highlight the rising levels of alcohol-related health harm
· Propose evidence-based solutions to reduce this harm
· Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA's Policy and Communications Officer, at matt.chorley@rcplondon.ac.uk or on 0203 075 1726.